TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: A prospective randomized trial

Annals of Surgery

Volumn 239, Issue 6, 2004, Pages 883-891

  Rosemurgy, Alexander S ^a,b   Zervos, Emmanuel E ^a   Clark, Whalen C ^a   Thometz, Donald P ^a   Black, Thomas J ^a   Zwiebel, Bruce R ^a   Kudryk, Bruce T ^a   Grundy, L Shane ^a   Carey, Larry C ^a   Henderson, J Michael ^c   Gadacz, Thomas R ^c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; FUROSEMIDE; SPIRONOLACTONE;

ADULT; ASCITES; CLINICAL ARTICLE; CONFERENCE PAPER; ENDOPROSTHESIS; FEMALE; HEPATIC VEIN; HUMAN; INFERIOR CAVA VEIN; INTERMETHOD COMPARISON; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERITONEAL FLUID; PERITONEUM VEIN SHUNT; PORTAL HYPERTENSION; PORTAL PHLEBOGRAPHY; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHUNTING; STENT; SURVIVAL RATE; TREATMENT OUTCOME; VENOUS PRESSURE;

AGED; ASCITES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERITONEOVENOUS SHUNT; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROBABILITY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 2442676638     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000128309.36393.71     Document Type: Conference Paper

References (22)

1. Cappone RR, Buhac I, Kohberger RC, et al. Resistant ascites in alcoholic liver cirrhosis: course and prognosis. Dig Dis Sci. 1978;23:867-871.
2. Guardiola J, Xiol X, Escribia JM, et al. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt. Am J Gastroenterol. 1995;90:2097-2102.
3. Lebrec D, Giuily N, Hadenque A, et al. Transjugular intrahepatic portosystemic shunt: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol. 1996;25:135-144.
4. Rossle M, Ochs A, Gulberg V, et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000;342:1701-1707.
5. Gines P, Uriz J, Calahorra B, et al. Transjugular intrahepatic portosystemic shunt vs paracentesis plus albumin for refractory ascites in cirrhosis: a multicenter randomized comparative trial. Gastroenterology. 2002;123:1839-1847.
6. Sanyal A, Gennings C, Reddy KR, et al. A randomized controlled trial of TIPS vs large volume paracentesis in the treatment of refractory ascites. Gastroenterology. 2003;124:634-643.
7. Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol. 2002;36:494-500.
8. Deschenes M, Dufresne M, Bui B, et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol. 1999;94:1361-1365.
9. Zervos E, McCormick J, Goode S, et al. Peritoneovenous shunts in patients with intractable ascites: palliation at what price? Am Surg. 1997;63:157-162.
10. Moskovitz M. The peritoneovenous shunt: expectations and reality. Am J Gastroenterol. 1990;77:917-929.
11. Stanley P, Ochhi S, Lee K, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med. 1989;321:1632-1638.
12. Gines P, Arroyo V, Vargus V, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med. 1991;325:829-835.
13. Rosemurgy A, Serafini F, Zweibel B, et al. Transjugular intrahepatic portasystemic shunt vs. small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial. J Gastrointestinal Surg. 2000;4:589-597.
14. Malinchoc M, Kamath P, Gordon F, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;4:864-871.
15. Kamath P, Wiesner R, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464-470.
16. Moore K, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the consensus conference of the international ascites club. Hepatology. 2003;38:258-266.
17. Zervos E, Rosemurgy A. Management of medically refractory ascites. Am J Surg. 2001;181:256-264.
18. Thuluvath P, Bal J, Mitchell S, et al. TIPS for the management of refractory ascites: response and survival are both unpredictable. Dig Dis Sci. 2003;48:542-550.
19. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites. N Engl J Med 1995;332:1192-1197.
20. Russo MW, Sood A, Jacobson IM, et al. Transjugular intrahepatic portosystemic shunt for refractory ascities: an analysis of the literature on efficacy, morbidity and mortality. Am J Gastro. 2003;11:2521-2527.
21. Angermayr B, Cejna M, Kamel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003;52:879-885.
22. Schepke M, Roth F, Fimmers R, et al. Comparison of MELD, Child-Pugh, and Emory Model for predicting survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol. 2003;98:1167-1174.